On March 30, 2026, SS Innovations International, Inc. announced that it has received regulatory approval for its SSi Mantra surgical robotic system in Colombia, Oman, Sri Lanka, and Kenya. This approval marks a significant milestone for the company as it expands its global footprint in the surgical robotics market. The SSi Mantra system is designed to make robotic surgery more affordable and accessible, particularly in underpenetrated markets. The approvals were granted by various regulatory bodies, including INVIMA in Colombia and the DGPA&DC in Oman, among others. Dr. Sudhir Srivastava, the company's CEO, emphasized the importance of democratizing access to advanced surgical technologies in underserved regions. The company is also pursuing FDA approval in the U.S. and CE marking in the European Union, with expectations for completion in mid-2026. This strategic expansion is expected to enhance the company's market position and drive future growth.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.